Stay updated on CVL-865 Adjunctive Therapy in Focal Seizures Clinical Trial
Sign up to get notified when there's something new on the CVL-865 Adjunctive Therapy in Focal Seizures Clinical Trial page.

Latest updates to the CVL-865 Adjunctive Therapy in Focal Seizures Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedCore content updated with a government funding status notice and an NIH hospital operating status, plus a version bump to v3.2.0 (replacing v3.1.0).SummaryDifference2% 
- Check33 days agoChange DetectedAdded version label v3.1.0 and removed multiple drug-safety topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) along with an older revision reference (v3.0.2); content now omits several core safety sections. If these deletions are intended, this is a major reduction in detailed drug-safety content.SummaryDifference0.2% 
- Check48 days agoChange DetectedVersion updated to v3.0.2; the Back to Top element was removed.SummaryDifference0.1% 
- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1% 
- Check62 days agoChange DetectedThe webpage has undergone significant updates, including the addition of various facility names and locations, particularly in Poland, South Korea, and Spain, while also removing some previously listed locations. Additionally, new terms related to drug safety and types of drugs have been introduced.SummaryDifference7% 
- Check76 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0% 
Stay in the know with updates to CVL-865 Adjunctive Therapy in Focal Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-865 Adjunctive Therapy in Focal Seizures Clinical Trial page.